Anti-RGS7BP monoclonal antibody

Pre-made anti-RGS7BP monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to RGS7BP/RGS7BP products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2701-Ab-1/ GM-Tg-hg-IP2701-Ab-2Anti-Human RGS7BP monoclonal antibodyHuman
GM-Tg-rg-IP2701-Ab-1/ GM-Tg-rg-IP2701-Ab-2Anti-Rat RGS7BP monoclonal antibodyRat
GM-Tg-mg-IP2701-Ab-1/ GM-Tg-mg-IP2701-Ab-2Anti-Mouse RGS7BP monoclonal antibodyMouse
GM-Tg-cynog-IP2701-Ab-1/ GM-Tg-cynog-IP2701-Ab-2Anti-Cynomolgus/ Rhesus macaque RGS7BP monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2701-Ab-1/ GM-Tg-felg-IP2701-Ab-2Anti-Feline RGS7BP monoclonal antibodyFeline
GM-Tg-cang-IP2701-Ab-1/ GM-Tg-cang-IP2701-Ab-2Anti-Canine RGS7BP monoclonal antibodyCanine
GM-Tg-bovg-IP2701-Ab-1/ GM-Tg-bovg-IP2701-Ab-2Anti-Bovine RGS7BP monoclonal antibodyBovine
GM-Tg-equg-IP2701-Ab-1/ GM-Tg-equg-IP2701-Ab-2Anti-Equine RGS7BP monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2701-Ab-1/ GM-Tg-hg-IP2701-Ab-2; GM-Tg-rg-IP2701-Ab-1/ GM-Tg-rg-IP2701-Ab-2;
GM-Tg-mg-IP2701-Ab-1/ GM-Tg-mg-IP2701-Ab-2; GM-Tg-cynog-IP2701-Ab-1/ GM-Tg-cynog-IP2701-Ab-2;
GM-Tg-felg-IP2701-Ab-1/ GM-Tg-felg-IP2701-Ab-2; GM-Tg-cang-IP2701-Ab-1/ GM-Tg-cang-IP2701-Ab-2;
GM-Tg-bovg-IP2701-Ab-1/ GM-Tg-bovg-IP2701-Ab-2; GM-Tg-equg-IP2701-Ab-1/ GM-Tg-equg-IP2701-Ab-2
Products NameAnti-RGS7BP monoclonal antibody
Formatmab
Target NameRGS7BP
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-RGS7BP monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2701-Ag-1Recombinant multi-species R7BP/ RGS7BP protein


    Target information

    Target IDGM-IP2701
    Target NameRGS7BP
    Gene ID401190,52882,294715,695221,609560,101080356,613327,100057970
    Gene Symbol and SynonymsA930030I01Rik,D13Bwg1146e,R7BP,RGD1309360,RGS7BP
    Uniprot AccessionQ6MZT1,Q5FVH8,Q08DH5
    Uniprot Entry NameR7BP_HUMAN,R7BP_RAT,R7BP_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000186479
    Target ClassificationN/A

    The target: RGS7BP, gene name: RGS7BP, also named as R7BP. This gene encodes a protein that binds to all members of the R7 subfamily of regulators of G protein signaling and regulates their translocation between the nucleus and the plasma membrane. The encoded protein could be regulated by reversible palmitoylation, which anchors it to the plasma membrane. Depalmitoylation localizes the protein to the nucleus. Polymorphisms in this gene may be associated with risk of aspirin-exacerbated respiratory disease. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Dec 2012].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.